Clinical trial
A Multicenter, Phase III, Open-label Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging
NCT00977093 is registered in ClinicalTrials.gov with Amersham Buchler, GmbH & Co KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Phase III, Open-label Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging
- Lead sponsor
- Amersham Buchler, GmbH & Co KG
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- June 30, 2004
- Enrollment
- 533 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.